The Essential Building Blocks of Effective Training The US Food and Drug Administration (FDA) has escalated its scrutiny of Indian pharmaceuticals and medical products. Beyond FDA, the same scrutiny is reflected in recent decisions by the Indian Supreme Court, regulations by agencies including the Central Drugs Standard Control Organisation...
“A more proactive interaction between
enforcement agencies and stakeholders such
as Indu8888stry, trade, chemists and doctors on a
regular basis is missing and this would help
in recognising early trends of drug abuse and
putting in control mechanisms to prevent
the same”, says Daara B Patel, Secretary-